methylene blue has been researched along with Shock in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (7.89) | 18.7374 |
1990's | 2 (5.26) | 18.2507 |
2000's | 7 (18.42) | 29.6817 |
2010's | 19 (50.00) | 24.3611 |
2020's | 7 (18.42) | 2.80 |
Authors | Studies |
---|---|
Dalia, AA; Devine, LT; Naoum, EE; Ortoleva, J; Roberts, RJ | 1 |
Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
Brokmeier, HM; Gerberi, DJ; Mara, KC; Nei, SD; Seelhammer, TG; Wieruszewski, PM; Wittwer, ED | 1 |
Czempik, PF; Krzych, ŁJ; Pluta, MP; Putowski, Z | 1 |
Russell, JA | 1 |
Canarie, MF; Funaro, M; Johnson, R; Otero Luna, AV; Pierce, RW | 1 |
Annich, G; Ben-Ari, J; Bitterman, Y; Eytan, D; Hadash, A; Hubara, E | 1 |
Evora, PRB; Gomes, WJ | 1 |
Gao, Y; Li, W; Pan, P; Wang, Y; Yu, X; Zhang, X | 1 |
Hoffman, RS; Jang, DH; Nelson, LS | 3 |
Evora, PR | 2 |
Braitberg, G; Fisher, J; Graudins, A; Taori, G | 1 |
Clark, RF; Darracq, MA; Lo, JC | 1 |
Bania, TC; Chu, J; Donovan, S; Hoffman, RS; Jang, DH; Nelson, LS | 1 |
Cartner, M; Graham, RE; Winearls, J | 1 |
Cole, JB; Laes, JR; Williams, DM | 1 |
Attias, O; Ben-Ari, J; Hadash, A; Hershman, E | 1 |
Belletti, A; Finco, G; Fominskiy, E; Hajjar, LA; Landoni, G; Monaco, F; Musu, M; Pasin, L; Saleh, O; Silvetti, S; Zangrillo, A | 1 |
Smolinske, S; Tataru, AP; Warrick, BJ | 2 |
Castro E Silva, O; Evora, PRB; Mente, ED; Mumic, FT; Silveira, MRG; Vilalva, KH | 1 |
Harding, SA; Hoffman, RS; Jang, DH | 1 |
Flynn, BC; Sladen, RN | 1 |
Aggarwal, N; Kupfer, Y; Seneviratne, C; Tessler, S | 1 |
Dalio, MB; Evora, PR; Viaro, F | 1 |
Poullis, M; Shackcloth, M | 1 |
HIFT, H; STRAWITZ, JG; TEMPLE, RL | 1 |
GREENBERG, HB | 1 |
Faber, P; Millar, BW; Ronald, A | 1 |
Evora, PR; Viaro, F | 1 |
Basile Filho, A; Basseto, S; Capellini, VK; Evora, PR; Rodrigues, AJ; Vicente, WV; Vicente, YA | 1 |
Brouckaert, P; Cauwels, A | 1 |
Rodriguez, LF; Smolik, LM; Zbehlik, AJ | 1 |
Dong, S; Su, J; Tang, C; Zhang, L; Zhang, Z; Zheng, S | 1 |
Oliva, PB | 1 |
14 review(s) available for methylene blue and Shock
Article | Year |
---|---|
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.
Topics: Adult; Humans; Hydroxocobalamin; Hypotension; Methylene Blue; Shock; Vasodilation; Vasoplegia | 2023 |
Successful Use of Methylene Blue in Catecholamine-Resistant Septic Shock: A Case Report and Short Literature Review.
Topics: Catecholamines; Humans; Methylene Blue; Nitric Oxide Synthase; Shock; Shock, Septic | 2023 |
Vasopressor therapy in critically ill patients with shock.
Topics: Angiotensin II; Critical Illness; Dopamine; Epinephrine; Humans; Methylene Blue; Norepinephrine; Phenylephrine; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2019 |
Methylene Blue for Refractory Shock in Children: A Systematic Review and Survey Practice Analysis.
Topics: Adult; Catecholamines; Child; Humans; Methylene Blue; Shock; Surveys and Questionnaires | 2020 |
[Methylene blue in the treatment of vasodilatory shock: a Meta-analysis].
Topics: Hemodynamics; Humans; Methylene Blue; Shock; Vasoconstrictor Agents | 2017 |
Methylene blue for distributive shock: a potential new use of an old antidote.
Topics: Anaphylaxis; Animals; Antidotes; Cyclic GMP; Drug Resistance; Endothelium, Vascular; Enzyme Inhibitors; Humans; Isoenzymes; Methylene Blue; Models, Biological; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Second Messenger Systems; Sepsis; Shock; Shock, Cardiogenic; Vascular Resistance | 2013 |
A review of methylene blue treatment for cardiovascular collapse.
Topics: Anaphylaxis; Enzyme Inhibitors; Humans; Methylene Blue; Shock; Shock, Septic | 2014 |
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.
Topics: Databases, Factual; Humans; Lypressin; Methylene Blue; Randomized Controlled Trials as Topic; Sepsis; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2015 |
A systematic analysis of methylene blue for drug-induced shock.
Topics: Calcium Channel Blockers; Databases, Factual; Evidence-Based Medicine; Hemodynamics; Humans; Methylene Blue; Nitric Oxide; Randomized Controlled Trials as Topic; Shock; Treatment Outcome | 2016 |
Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.
Topics: Adult; Animals; Cardiopulmonary Bypass; Child; Enzyme Inhibitors; Female; Humans; Hypotension; Infant, Newborn; Methylene Blue; Nitric Oxide; Postoperative Complications; Pregnancy; Sepsis; Shock; Vasodilation | 2005 |
The guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutical target.
Topics: Animals; Drug Delivery Systems; Enzyme Inhibitors; Guanylate Cyclase; Humans; Methylene Blue; Shock | 2006 |
Benzocaine-induced methemoglobinemia: report of a severe reaction and review of the literature.
Topics: Administration, Topical; Aged; Aged, 80 and over; Benzocaine; Humans; Infusions, Intravenous; Male; Methemoglobinemia; Methylene Blue; Shock | 1994 |
Lactic acidosis.
Topics: Acidosis; Alcoholic Intoxication; Anemia; Animals; Bicarbonates; Cardiac Output; Diabetes Mellitus; Epinephrine; Extracorporeal Circulation; Glucose; Glycogen Storage Disease; Humans; Hyperventilation; Hypoxia; Lactates; Leukemia; Liver; Methylene Blue; Peritoneal Dialysis; Phenformin; Physical Exertion; Pyruvates; Renal Dialysis; Shock; Shock, Hemorrhagic; Tromethamine | 1970 |
24 other study(ies) available for methylene blue and Shock
Article | Year |
---|---|
Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study.
Topics: Adult; Humans; Intensive Care Units; Methylene Blue; Retrospective Studies; Shock; Vasodilation | 2022 |
Methylene Blue Administration for Distributive Shock States in Critically Ill Children.
Topics: Blood Pressure; Child; Child, Preschool; Critical Illness; Fatal Outcome; Female; Humans; Infant; Infant, Newborn; Israel; Male; Methylene Blue; Retrospective Studies; Shock; Shock, Septic; Vasoplegia | 2020 |
Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? "Reasons That Reason Itself Does Not Know…".
Topics: Cardiopulmonary Bypass; Humans; Methylene Blue; Shock | 2021 |
Methylene blue does not have to be considered only as rescue therapy for distributive shock.
Topics: Animals; Antidotes; Endothelium, Vascular; Enzyme Inhibitors; Humans; Methylene Blue; Models, Biological; Second Messenger Systems; Shock | 2013 |
Response to methylene blue does not have to be considered only as rescue therapy for distributive shock.
Topics: Animals; Antidotes; Endothelium, Vascular; Enzyme Inhibitors; Humans; Methylene Blue; Models, Biological; Second Messenger Systems; Shock | 2013 |
Methylene blue used in the treatment of refractory shock resulting from drug poisoning.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antidotes; Antipsychotic Agents; Blood Gas Analysis; Blood Pressure; Carbamazepine; Dibenzothiazepines; Electrocardiography; Fluid Therapy; Fluoxetine; Humans; Hypnotics and Sedatives; Hypotension; Male; Methylene Blue; Oxazepam; Quetiapine Fumarate; Shock; Valproic Acid; Vasoconstrictor Agents | 2014 |
Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Disease Models, Animal; Free Radical Scavengers; Guanylate Cyclase; Methylene Blue; Rats, Sprague-Dawley; Shock | 2015 |
A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.
Topics: Acidosis; Adult; Drug Overdose; Fluid Therapy; Gliclazide; Humans; Male; Metformin; Methylene Blue; Shock; Vasoconstrictor Agents; Vasoplegia | 2015 |
Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report.
Topics: Amlodipine; Atenolol; Hemodynamics; Humans; Male; Methylene Blue; Middle Aged; Shock; Valsartan; Vasodilation | 2015 |
Methylene blue treatment for resistant shock following renal transplantation.
Topics: Adult; Female; Humans; Kidney Transplantation; Methylene Blue; Postoperative Complications; Shock; Vasoplegia; Young Adult | 2015 |
Methylene Blue and Cardiovascular Collapse.
Topics: Anaphylaxis; Enzyme Inhibitors; Humans; Methylene Blue; Shock | 2016 |
Use of Methylene Blue to Treat Hypovolemic Shock Followed by Ischemia-Reperfusion Injury in the Postoperative Orthotopic Liver Transplant Patient: A Case Report.
Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Liver Transplantation; Methylene Blue; Middle Aged; Non-alcoholic Fatty Liver Disease; Reperfusion Injury; Shock; Treatment Outcome; Vasoplegia | 2018 |
In response to: "A systematic analysis of methylene blue for drug-induced shock".
Topics: Humans; Methylene Blue; Shock; Shock, Septic | 2017 |
A systematic analysis of methylene blue for drug-induced shock in humans.
Topics: Humans; Methylene Blue; Shock; Shock, Septic | 2017 |
The use of methylene blue for vasodilatory shock in a pediatric lung transplant patient.
Topics: Adolescent; Antidotes; Cystic Fibrosis; Female; Humans; Lung Transplantation; Methylene Blue; Nitric Oxide; Postoperative Complications; Shock; Vasodilation | 2009 |
Methylene blue in the treatment of refractory shock from an amlodipine overdose.
Topics: Adult; Amlodipine; Cyclic GMP; Female; Humans; Methylene Blue; Shock; Vasodilator Agents | 2011 |
Methylene blue reverses recalcitrant shock in β-blocker and calcium channel blocker overdose.
Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Drug Overdose; Enzyme Inhibitors; Female; Humans; Methylene Blue; Shock | 2013 |
Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice?
Topics: Anaphylaxis; Animals; Cyclic GMP; Endothelium, Vascular; Hemodynamics; Humans; Methylene Blue; Nitric Oxide; Protamines; Shock | 2002 |
Catastrophic cardiovascular adverse reactions to protamine.
Topics: Hemodynamics; Humans; Methylene Blue; Nitric Oxide; Protamines; Shock; Vascular Resistance | 2003 |
The effect of methylene blue and ascorbic acid in hemorrhagic shock.
Topics: Ascorbic Acid; Humans; Methylene Blue; Shock; Shock, Hemorrhagic; Vitamins | 1958 |
SYNCOPE AND SHOCK DUE TO METHEMOGLOBINEMIA.
Topics: Administration, Intravenous; Adolescent; Aniline Compounds; Humans; Injections; Injections, Intravenous; Ink; Methemoglobinemia; Methylene Blue; Shock; Syncope; Toxicology | 1964 |
Is the cyclic GMP system underestimated by intensive care and emergency teams?
Topics: Animals; Blood Circulation; Blood Pressure; Catecholamines; Critical Care; Cyclic GMP; Emergency Medicine; Humans; Inflammation; Lactates; Methylene Blue; Models, Biological; Nitric Oxide; Norepinephrine; Shock | 2007 |
Critical role for small and large conductance calcium-dependent potassium channels in endotoxemia and TNF toxicity.
Topics: Animals; Apamin; Calcium; Endotoxemia; Female; Gene Expression Regulation; Glyburide; Hypoglycemic Agents; Methylene Blue; Mice; Mice, Inbred C57BL; Peptides; Potassium Channels; Shock; Tumor Necrosis Factor-alpha | 2008 |
[The effect of NO-like relaxing factor on vascular reactivity in tourniquet shock rat].
Topics: Animals; Cyclic GMP; Guanylate Cyclase; Male; Methylene Blue; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Wistar; Shock; Tourniquets; Vasoconstriction | 1997 |